Abbott (ABT) Tops Q1 EPS by 10c, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Abbott Labs (ABT) PT Raised to $140 at Cowen
January 27, 2021 4:24 PM ESTCowen analyst Joshua Jennings raised the price target on Abbott Labs (NYSE: ABT) to $140.00 (from $113.00) while maintaining a Outperform rating.
The analyst comments "ABT finished 2020 with 28% organic sales growth and guided to 2021 EPS growth of more than 35%, which still looks conservative. We have... More
